• PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical Trial

    PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical TrialShares in PhaseBio Pharmaceuticals (PHAS) surged 82% in after-hours trading on Wednesday, after the company announced clearance of its investigational new drug (IND) application by the FDA under its Coronavirus Treatment Acceleration Program (CTAP).PhaseBio’s “VANGARD” trial will assess the efficacy and safety of its PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome. Approximately 210 patients will be targeted to be enrolled at approximately 20 sites across the US. The primary endpoint will measure days alive and free of respiratory failure.The patients will be treated with PB1046, a novel, once-weekly, subcutaneously-injected vasoactive intestinal peptide (VIP) receptor agonist that targets VPAC receptors in the cardiovascular, pulmonary and immune systems. VIP is a neurohormone known to have anti-inflammatory effects, and importantly, has also been observed to have potent bronchodilatory and immunomodulatory effects in the respiratory system.PhaseBio now expects to begin dosing patients by the end of June and is targeting to report trial results late in the fourth quarter of 2020. Based on feedback from the FDA, PhaseBio believes that positive, clearly interpretable and clinically meaningful results from this trial may enable PhaseBio to submit a Biologics License Application.“Physicians are in desperate need of new options to treat COVID-19 patients facing rapid deterioration of lung function and before progressing to a ventilator,” said John Lee, CMO at PhaseBio. “Early mitigation by PB1046 of the effects of inflammatory cytokines that can cause acute lung injury, is a promising strategy that could prevent patients from declining to the point where they require mechanical ventilation and help alleviate the strain on critical care infrastructure that we’re witnessing.”Indeed, analysts have a firmly bullish outlook on PHAS with 4 recent buy ratings, no holds and no sells, giving it a Strong Buy consensus. The average analyst price target stands at $12.75 (188% upside potential). (See PhaseBio stock analysis on TipRanks).Related News: Novavax Begins Human Testing For Covid-19 Vaccine, Expects Results In July Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline Regeneron Announces Secondary Offering Pricing At $515/Share More recent articles from Smarter Analyst: * Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses; Top Analyst Ramps Up PT To $61 * Hertz Sinks 11% After-Hours As Carl Icahn Sells Stake At $1.8B Loss * Data Center Set to Send Nvidia Stock Soaring Even Higher * Google Pay App May Face Anti-Trust Probe In India – Report

    from Yahoo Finance https://ift.tt/3gyOdFA

  • 3 top ASX dividend shares to buy this June

    street sign saying yield, asx dividend shares

    With June almost upon us (insert obligatory comment about how fast the year is flying by), it’s a great opportunity to examine our ASX share portfolios, and particularly our dividend shares.

    2020 has been a topsy-turvy year so far for many reasons, with the shifting paradigm for ASX dividend shares part of the story.

    Former ASX dividend share stalwarts like the banks are now dividend cutters. ‘Safe’ ASX shares like Transurban Group (ASX: TCL) are leaving income investors hanging.

    So if I wanted to top up my portfolio’s income potential this June, here are 3 ASX shares I would use to do so:

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

    ‘Soul Patts’ is one of the best dividend shares on the ASX (in my opinion) and also one of the only shares I trust to keep its dividend flowing this year. In fact, I believe it to be ASX dividend royalty. Soul Patts has paid out a dividend every year of its existence (which goes back to 1903). Not only that, but this company has also increased its dividend payments every year for the last 20 years.

    Soul Patts’ large stakes in ASX shares like TPG Telecom Ltd (ASX: TPM) and Brickworks Limited (ASX: BKW) pour cash into the company’s coffers, whilst also giving it broad exposure to the Australian economy. Thus, if I had to choose a dividend share to buy this June, Soul Patts would be at the top of my list.

    WAM Research Limited (ASX: WAX)

    WAM Research isn’t too far behind though. This is a Listed Investment Company (LIC) that invests in small and mid-cap ASX shares like Tassal Group Limited (ASX: TGR) and City Chic Collective Ltd (ASX: CCX).

    This company has proven its know-how, in my view, having delivered an average annual return of 13.4% over the past 10 years. On current prices, WAM Research shares are offering a trailing yield of 6.99%. Although WAX shares usually trade at a premium to their underlying Net Asset Value, I believe this hefty yield more than makes up for this fact.

    SPDR S&P Global Dividend Fund (ASX: WDIV)

    My last ASX dividend share for June is actually an exchange-traded fund (ETF). WDIV invests in dividend-paying companies from beyond our shores, specifically those which have held or increased their dividends for 10 years or longer. Its holdings are balanced fairly evenly between American, Canadian and Japanese companies, with the United Kingdom, France, Hong Kong and Australia also represented.

    Thus, I think this ETF can provide some great global exposure and diversification to an ASX dividend portfolio. Some of its top holdings include Freenet AG, Enagas, Japan Tobacco and our own AGL Energy Limited (ASX: AGL). WDIV offers a trailing yield of 6.01%.

    For another top ASX dividend share, take a look at the report below!

    NEW: Expert names top dividend stock for 2020 (free report)

    When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*

    Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.

    This fully franked “under the radar” company is currently trading more than 24% below its all-time high and paying a 6.7% grossed-up dividend.

    The name of this dividend dynamo and the full investment case is revealed in this brand new free report.

    But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.

    See the top dividend stock for 2020

    More reading

    Motley Fool contributor Sebastian Bowen owns shares of SPDR S&P Global Dividend Fund, WAM Research Limited, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 top ASX dividend shares to buy this June appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3daG1co

  • Cassini Resources share price sets new 52-week high following promising exploration update

    business men digging up dollar sign

    The Cassini Resources Ltd (ASX: CZI) share price has had an impressive run on the market today, up by as much as 13.04% in early morning trade to a new 52-week high of 13 cents.

    The small-cap ASX miner provided an encouraging exploration update for its Yarawindah Project this morning, which has gotten investors enthused.

    About Cassini Resources

    Cassini Resources is a base and precious metals developer and explorer based in Perth. Its flagship site is the West Musgrave Project, the largest undeveloped nickel-copper project in Australia.

    It also has a joint venture agreement with S&P/ASX 200 Index (ASX: XJO) mining share OZ Minerals Limited (ASX: OZL), along with its Mt Squires Gold Project and the subject of today’s announcement, the Yarawindah Project.

    Why has the Cassini Resources share price bounced?

    This morning, Cassini Resources provided an exploration update for its Yarawindah Project. The project is located 100km northeast of Perth and is prospective for nickel, copper, cobalt and platinum group elements (PGE). It’s part of an emerging new nickel-copper-cobalt-PGE province that has been validated by a recent high-grade discovery by Chalice Gold Mines Limited (ASX: CHN).

    In today’s release, Cassini Resources detailed encouraging sulphide intercepts at the Ovis Prospect. The first 2 drill holes of the diamond drilling program at the Ovis Prospect have been completed.

    Cassini announced that “visually encouraging zones” of nickel and copper sulphides have been intersected over a 10-metre zone in YAD0020 at Ovis.

    Meanwhile, a third hole is in progress to test a new electromagnetic (EM) anomaly 1km along strike to the north of Ovis.

    In addition, the company has received 200m-spaced infill soil results and partly completed surface EM survey results along the Brassica NW trend.

    According to the announcement, “the EM survey has defined a 90m x 65m, 1,500 siemens conductor at the XC06 anomaly”.

    In light of these results, the XC06 anomaly is now considered a high-priority target for immediate drill testing. Cassini intends to move the rig to XC06 following completion of the third hole later this week.

    The Cassini Resources share price is sitting 4.35% higher for the day at the time of writing, with shares last changing hands at 12 cents.

    5 “Bounce Back” Stocks To Tame The Bear Market (FREE REPORT)

    Master investor Scott Phillips has sifted through the wreckage and identified the 5 stocks he thinks could bounce back the hardest once the coronavirus is contained.

    Given how far some of them have fallen, the upside potential could be enormous.

    The report is called 5 Stocks For Building Wealth after 50, and you can grab a copy for FREE for a limited time only.

    But you will have to hurry — history has shown the market could bounce significantly higher before the virus is contained, meaning the cheap prices on offer today might not last for long.

    See the 5 stocks

    More reading

    Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Cassini Resources share price sets new 52-week high following promising exploration update appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XAcCSd

Sorry, but nothing was found. Please try a search with different keywords.